Search results
Pfizer COVID-19 vaccine 73 percent effective in children under 5
The Hill via Yahoo News· 2 years agoPfizer’s COVID-19 vaccine was 73.2 percent effective against the disease in children under 5, the...
Pfizer's COVID-19 vaccine candidate shown to be 90% effective in early findings
USA TODAY via Yahoo News· 2 years agoIn a major boost to vaccine development, Pfizer and its collaborator BioNTech released early study...
The FDA Now Wants Fall COVID Vaccines to Target KP.2—But Not All Manufacturers Can Pivot
Verywell Health via Yahoo News· 20 hours agoLess than a week after telling COVID-19 vaccine manufacturers to target the JN.1 variant this fall,...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 4 hours agoNovavax stock rocketed to a nearly two-year high in June, thanks to a $1.3 billion deal and the...
Pfizer looks to charge at least $110 a dose for COVID-19 vaccine next year
The Hill via Yahoo News· 2 years agoPfizer expects to roughly quadruple the price of its COVID-19 vaccine to between $110 to $130 per...
Pfizer, BioNTech say bivalent COVID-19 booster shot performs better against BA.5 omicron subvariant
Good Morning America via Yahoo News· 2 years agoAmerican pharmaceutical company Pfizer and its German partner BioNTech announced Friday that a...
FDA advisory committee votes unanimously in favor of a one-shot COVID-19 vaccine approach – 5...
The Conversation via Yahoo News· 1 year agoThe FDA advisory committee discussed vaccine safety, effectiveness of the current shots, potential...
Next COVID vaccine booster shot should target new variant not original virus, FDA panel says
USA TODAY via Yahoo News· 1 year agoThis fall's COVID-19 vaccine should target the XBB.1.5 variant and for the first time not take aim...
Should I get a COVID shot? CDC says most should wait for September
CBS News via Yahoo News· 10 months agoUpdate: The new COVID vaccines from Moderna and Pfizer have been greenlighted by the FDA and CDC and...
BioNTech Dives As Pfizer Partner Reports Lagging Covid Vaccine Sales, Guidance
Investor's Business Daily· 2 years agoGerman Covid vaccine developer BioNTech lagged second-quarter estimates and reiterated disappointing...